Results 51 to 60 of about 624,745 (162)

Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling

Cellular Physiology and Biochemistry, 2017
Tumor necrosis factor (TNF)-related weak inducer of apoptosis (TWEAK) engages its sole receptor, fibroblast growth factor–inducible 14 (Fn14), which participates in various inflammatory and immunologic processes.
Xuening Wang, Shengxiang Xiao, Yumin Xia
doaj   +1 more source

Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2)

International Journal of Mycobacteriology, 2016
Objective/Background: The susceptibility to tuberculosis (TB) depends upon different factors, and the risk of developing diseases after infection with Mycobacterium tuberculosis ranges from 5% to 10%.
Ehsan Ghamari, Poopak Farnia, Shima Saif, Mehran Marashian, Jaladein Ghanavi, Payam Tabarsi, Parissa Farnia, Ali Akbar Velayati   +7 more
doaj   +1 more source

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]

Biologics: Targets & Therapy, 2014
Thorlund K, Druyts E, Aviña-Zubieta JA, et al. Biologics: Targets and Therapy. 2012;6:417–427. On page 418, note that under Search strategy, Merck-Shire-Dome should have been listed as Merck, Sharp, and Dohme.On page 421, Figure 2, the ...
Thorlund K, Druyts E, Aviña-Zubieta JA, Mills EJ   +3 more
doaj  

Entamoeba histolytica – tumor necrosis factor: a fatal attraction

Microbial Cell, 2015
Serge Ankri
doaj   +1 more source

Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis

Biologics: Targets & Therapy, 2013
Filipe Seguro Paula,1 José Delgado Alves1,2 1Immunomediated Systemic Diseases Unit, Department of Medicine 4, Fernando Fonseca Hospital, Amadora, 2Center for the Study of Chronic Diseases, Department of Pharmacology, Faculty of Medical Sciences ...
Paula FS, Delgado Alves J
doaj  

Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease

International Journal of COPD, 2008
Fanny WS Ko1, Ting-Fan Leung2, Gary WK Wong2, Jenny Ngai1, Kin W To1, Susanna Ng1, David SC Hui11Department of Medicine and Therapeutics; 2Department of Pediatrics, The Chinese University of Hong Kong, Hong KongBackground: Assessment of airway ...
Fanny WS Ko, Ting-Fan Leung, Gary WK Wong, Jenny Ngai, Kin W To, et al   +5 more
doaj  

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis

Patient Preference and Adherence, 2013
Virginia Martínez-Santana,1 E González-Sarmiento,2 MA Calleja-Hernández,3 T Sánchez-Sánchez1 1Pharmacy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain; 2Internal Medicine Department ...
Martínez-Santana V, González-Sarmiento E, Calleja-Hernández MA, Sánchez-Sánchez T   +3 more
doaj  

Apoptosis of peripheral blood mononuclear cells in patients with sepsis

Indian Journal of Pathology and Microbiology, 2010
Context: Recent investigations into the pathogenesis of sepsis reveal an important role for apoptosis. The present study was designed in order to assess the peripheral blood mononuclear cells′ (PBMCs) apoptosis and the plasma levels of molecules ...
Jadali Zohreh, Amiri Mohammad, Ravanbakhsh Massoud   +2 more
doaj  

On the heartbreak of anti-tumor necrosis factor drugs. [PDF]

Proc (Bayl Univ Med Cent)
Schiller L.
europepmc   +1 more source

Acne treated with tumor necrosis factor inhibitors. [PDF]

JAAD Int
Bizuneh LG, Coates SJ, Naik HB, Mathes E, Amerson E.   +4 more
europepmc   +1 more source